Vimarsana
Biggest News Aggregation in the World

Page 5 - Sosei Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sosei Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sosei Group Today - Breaking & Trending Today

Sosei Heptares - Investor and Press Conference on Today's - Vimarsana News

Sosei Heptares - Investor and Press Conference on Today's

Tokyo, Japan and Cambridge, UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s...

Sosei buys Idorsia Pharmaceuticals' Japan, Korea units for $466 mln - Vimarsana News

Sosei buys Idorsia Pharmaceuticals' Japan, Korea units for $466 mln

Japanese biopharma Sosei Group has bought Swiss-based Idorsia Pharmaceuticals' businesses in Japan and South Korea for about 65 billion yen in its largest acquisition to date. In a...

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million - Vimarsana News

Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd today announced the sale of its operating businesses in the Asia Pacific region , including...

GNW-Adhoc: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million - Vimarsana News

GNW-Adhoc: Idorsia sells its Asia Pacific (ex-China) operations - including select license rights to products - to Sosei Heptares for a total consideration of CHF 400 million

^Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating businesses in the Asia Pacific (ex-China) region ("Territory"), including assignment of PIVLAZ (clazosentan) and license rights to daridorexant in ...

Idorsia sells its Asia Pacific (ex-China) operations – - Vimarsana News

Idorsia sells its Asia Pacific (ex-China) operations –

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – July 20, 2023 Idorsia Ltd (SIX: IDIA) today announced the sale of its operating...